Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.
about
Sphingolipids in High Fat Diet and Obesity-Related DiseasesOn ceramides, other sphingolipids and impaired glucose homeostasisDefect of insulin signal in peripheral tissues: Important role of ceramideNeonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary ReportAttenuating the Biologic Drive for Weight Regain Following Weight Loss: Must What Goes Down Always Go Back Up?Plasma sphingosine-1-phosphate is elevated in obesityBiomarkers of NAFLD progression: a lipidomics approach to an epidemic.n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: the multi-ethnic study of atherosclerosis.New evidence for the role of ceramide in the development of hepatic insulin resistance.Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes.Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway.Temporal changes in sphingolipids and systemic insulin sensitivity during the transition from gestation to lactationEndurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice.Glycosphingolipids and cell death: one aim, many waysSecond-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Targeting ceramide metabolism in obesity.Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.Alterations of specific lipid groups in serum of obese humans: a review.Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.Plasma ceramides are elevated in overweight Holstein dairy cows experiencing greater lipolysis and insulin resistance during the transition from late pregnancy to early lactation.Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.Sphingolipids in obesity and related complications.Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.Ceramides mediate cigarette smoke-induced metabolic disruption in mice.Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.Activation of Sphingolipid Pathway in the Livers of Lipodystrophic Agpat2-/- Mice.Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis
P2860
Q26773230-58168942-C2C6-4AD8-A609-0C52B865B874Q27021446-EE1E44AC-AE4A-436E-A485-0CCFBA853FE7Q27690875-10CC68DF-E3D0-483B-A9BF-CC632EA2DF96Q33616820-8CCC7DE4-F6F4-4198-9431-96207624B681Q33749354-0BD28D60-3F70-48E8-A678-69483FB563E9Q34988407-8223882A-A857-46C5-AB20-4AC0AD83F87DQ35120968-A0C8A2FE-72C0-48B2-B90B-A40096BC4928Q35207918-272BF8B6-6702-4B58-8580-03DF88858F44Q35551917-E6AD63B6-2596-45C8-B9C5-7F724D79F8FAQ35788303-D0CCB082-BD0E-4C15-B0BE-C2E91356F5B3Q35903260-F677B138-2DF9-47B2-AAD2-F101AFEFBAEAQ36366979-B7A04590-9A21-4106-B148-602B00CC523AQ36405704-78E138DE-6286-45F1-8BC0-E85F8F543DBCQ36405917-5D1C37FA-CDE0-4968-B766-C1D981691045Q36570916-B522D036-D0CB-47D7-A5EA-950B98DB039EQ38833111-FF6410FC-3F80-4AA1-A0E6-FFBB4C4DFA74Q38887432-448ADEC0-003C-4D38-9B1F-5DCB61B83C00Q38916357-51D37CDA-22C5-4906-AF3B-35B347FB59F7Q39023727-2DC9ABBB-31E3-4227-867D-75ACD3D956C1Q39376014-D5F4F214-B18E-467F-BD55-296A561FBE97Q40186924-9C4C9FDB-DAD6-443E-BDBA-266118A4B917Q40569862-8DE17944-FF05-4C70-B378-D7A923338A9BQ40955387-2F4ED5EC-9DF9-42C4-A279-037EB00AEC5BQ45046493-07E1DCF6-FDBC-4ED9-A2A3-5E7A60D1B09FQ45072496-2348FFFA-8100-4C9D-BB9A-62BFAD374C99Q50631457-2311680C-D082-4AAB-92E9-776E3D8319ACQ53573537-25FEEAED-52EE-47EF-8E75-232053F23C6EQ53714395-99B0C147-353D-49F1-A9C1-6A6C8E9C1F6CQ57817278-7FDB73FA-0CFB-47BC-928B-4C49BC06DE72
P2860
Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@ast
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@en
type
label
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@ast
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@en
prefLabel
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@ast
Regulation of plasma ceramide ...... de novo synthesised ceramide.
@en
P2093
P2860
P50
P1433
P1476
Regulation of plasma ceramide ...... s de novo synthesised ceramide
@en
P2093
A C Barnett
J F Horowitz
P2860
P2888
P304
P356
10.1007/S00125-012-2649-3
P577
2012-07-27T00:00:00Z